Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Atumelnant

Copy Product Info
😃Good
Catalog No. T86091Cas No. 2392970-97-5
Alias CRN04894, CRN 04894

Atumelnant (CRN04894) is a selective and potent MC2R antagonist that inhibits ACTH-stimulated corticosterone secretion in a dose-dependent manner for the study of congenital adrenocortical hyperplasia (CAH) and Cushing's disease (CD).

Atumelnant

Atumelnant

Copy Product Info
😃Good
Purity: 98.41%
Catalog No. T86091Alias CRN04894, CRN 04894Cas No. 2392970-97-5
Atumelnant (CRN04894) is a selective and potent MC2R antagonist that inhibits ACTH-stimulated corticosterone secretion in a dose-dependent manner for the study of congenital adrenocortical hyperplasia (CAH) and Cushing's disease (CD).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.41%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Atumelnant (CRN04894) is a selective and potent MC2R antagonist that inhibits ACTH-stimulated corticosterone secretion in a dose-dependent manner for the study of congenital adrenocortical hyperplasia (CAH) and Cushing's disease (CD).
Targets&IC50
MC2R (rat):0.23 nM (KB), MC2R (human):0.34 nM (KB)
In vitro
Atumelnant is an orally potent MC2R antagonist that inhibits corticosterone secretion induced by adrenocorticotropic hormone (ACTH) stimulation in a rat model. Atumelnant has a binding constant (KB value) of 0.34 nM for human MC2R and 0.23 nM for rat MC2R. [1]
In vivo
In an ACTH-stimulated male rat model, single oral administration of Atumelnant at 3 mg/kg and 30 mg/kg significantly and dose-dependently reduced corticosterone secretion levels. [1]
SynonymsCRN04894, CRN 04894
Chemical Properties
Molecular Weight613.71
FormulaC33H42F3N5O3
Cas No.2392970-97-5
SmilesC(=O)(C1(C(F)(F)F)CCC1)N2C[C@@H](CC)N(CC2)C3=C(C(N[C@H]4C5CCN(C4)CC5)=O)N=C(C=C3)C6=C(OCC)C=CC=C6
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (130.35 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6294 mL8.1472 mL16.2943 mL81.4717 mL
5 mM0.3259 mL1.6294 mL3.2589 mL16.2943 mL
10 mM0.1629 mL0.8147 mL1.6294 mL8.1472 mL
20 mM0.0815 mL0.4074 mL0.8147 mL4.0736 mL
50 mM0.0326 mL0.1629 mL0.3259 mL1.6294 mL
100 mM0.0163 mL0.0815 mL0.1629 mL0.8147 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Atumelnant | purchase Atumelnant | Atumelnant cost | order Atumelnant | Atumelnant chemical structure | Atumelnant in vivo | Atumelnant in vitro | Atumelnant formula | Atumelnant molecular weight